Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Reflex and Kras[original query] |
---|
Reflex testing of resected stage I through III lung adenocarcinomas for EGFR and KRAS mutation: report on initial experience and clinical utility at a single center. The Journal of thoracic and cardiovascular surgery 2011 Feb 141 (2): 476-80. D'Angelo Sandra P, Park Bernard, Azzoli Christopher G, Kris Mark G, Rusch Valerie, Ladanyi Marc, Zakowski Maureen |
Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012 Dec 7 (12): 12. D'Angelo SP, Janjigian YY, Ahye N, Riely GJ, Chaft JE, Sima CS, Shen R, Zheng J, Dycoco J, Kris MG, Zakowski MF, Ladanyi M, Rusch V, Azzoli CG |
Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: a retrospective study of the Lebanese population. Oncology reports 2014 Nov 32 (5): 2223-9. Fakhruddin Najla, Mahfouz Rami, Farhat Fadi, Tfayli Arafat, Abdelkhalik Rabab, Jabbour Mark, Yehia Lamis, Mahfoud Ziyad, Zaatari Gha |
Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations. Archives of pathology & laboratory medicine 2017 Dec . Mehrad Mitra, Roy Somak, Bittar Humberto Trejo, Dacic San |
Cytomorphologic characteristics of next-generation sequencing-positive bile duct brushing specimens. Journal of the American Society of Cytopathology 2020 Jul . Rosenbaum Matthew W, Arpin Ronald, Limbocker Jessica, Casey Brenna, Le Long, Dudley Jonathan, Iafrate A John, Pitman Martha |
Outcomes and prognostic contributors in patients with KRAS mutated non-small cell pulmonary adenocarcinomas: a single institution experience. Journal of thoracic disease 2021 9 13 (8): 4785-4796. Burns Ethan A, Ensor Joe E, Hsu Jim, Thomas Jessica S, Olsen Randall J, Bernicker Eric |
High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor Content. JCO precision oncology 2021 7 5 . Meador Catherine B, Milan Marina S D, Hu Emmy Y, Awad Mark M, Rabin Michael S, Paweletz Cloud P, Hartmaier Ryan, Laus Gianluca, Oxnard Geoffrey |
Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 2022 Jun 29 (7): 4428-4437. Kuang Shelley, Fung Andrea S, Perdrizet Kirstin A, Chen Kaitlin, Li Janice J N, Le Lisa W, Cabanero Michael, Karsaneh Ola Abu Al, Tsao Ming S, Morganstein Josh, Ranich Laura, Smith Adam C, Wei Cuihong, Cheung Carol, Shepherd Frances A, Liu Geoffrey, Bradbury Penelope, Pal Prodipto, Schwock Joerg, Sacher Adrian G, Law Jennifer H, Stockley Tracy L, Leighl Natasha |
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study. JTO clinical and research reports 2022 4 3 (4): 100301. Thompson Jeffrey C, Aggarwal Charu, Wong Janeline, Nimgaonkar Vivek, Hwang Wei-Ting, Andronov Michelle, Dibardino David M, Hutchinson Christoph T, Ma Kevin C, Lanfranco Anthony, Moon Edmund, Haas Andrew R, Singh Aditi P, Ciunci Christine A, Marmarelis Melina, D'Avella Christopher, Cohen Justine V, Bauml Joshua M, Cohen Roger B, Langer Corey J, Vachani Anil, Carpenter Erica |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: